Search by Drug Name or NDC
NDC 00067-2039-50 EXCEDRIN 250; 250; 65 mg/1; mg/1; mg/1 Details
EXCEDRIN 250; 250; 65 mg/1; mg/1; mg/1
EXCEDRIN is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 00067-2039 |
|---|---|
| Product ID | 0067-2039_06183414-a911-4a52-8f13-c78e3ec52956 |
| Associated GPIs | 64990003200350 |
| GCN Sequence Number | 040186 |
| GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 10414 |
| HICL Sequence Number | 001807 |
| HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Brand |
| Proprietary Name | EXCEDRIN |
| Proprietary Name Suffix | MIGRAINE |
| Non-Proprietary Name | Acetaminophen, Aspirin (NSAID) and Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020802 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00067-2039-50 (00067203950)
| NDC Package Code | 0067-2039-50 |
|---|---|
| Billing NDC | 00067203950 |
| Package | 1 BOTTLE in 1 CARTON (0067-2039-50) / 50 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2010-02-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |